Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.92
- Piotroski Score 7.00
- Grade In-Line
- Symbol (OSUR)
- Company OraSure Technologies, Inc.
- Price $4.27
- Changes Percentage (0.47%)
- Change $0.02
- Day Low $4.18
- Day High $4.31
- Year High $8.45
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 01/08/1998
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 11/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $4.50
- High Stock Price Target $4.50
- Low Stock Price Target $4.50
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.30
- Trailing P/E Ratio 15.63
- Forward P/E Ratio 15.63
- P/E Growth 15.63
- Net Income $53.66 M
Income Statement
Quarterly
Annual
Latest News of OSUR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Chemist, pub and bank closures lead to 2,300 more empty UK stores, survey finds
High streets in Great Britain faced a wave of closures by chemist, pub, and bank chains, resulting in almost 2,300 empty stores in the first half of the year. Retail parks and shopping centers fared b...
By The Guardian | 11 hours ago -
Slave Lake residents speak about homeless shelter's closure as fall and winter approach - Edmonton | Globalnews.ca
After closing Slave Lake's only homeless shelter due to safety concerns, the town faces challenges in supporting homeless residents. Despite crime rate staying the same, residents like Lynn Bowes supp...
By Global News | 2 days ago -
First case of human bird flu diagnosed without exposure to infected animals, CDC says
A patient in Missouri hospitalized with bird flu had no animal contact. CDC confirmed avian influenza A (H5) case. Patient treated and discharged, marking 14th US case. Concerns arise on human-to-huma...
By Fox News | 2 days ago
